Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe 

Slides:



Advertisements
Similar presentations
T cells Jan Novák. The immune system Protection against infectious agents Clearance of dying, damaged and dangerous cells Regulation of the immune responses.
Advertisements

Immunology molecular medicine 3 Conleth Feighery.
Immunology 2 nd Med 2009 Some revision points Con Feighery.
Cell-to-Cell Transfer of M. tuberculosis Antigens Optimizes CD4 T Cell Priming Smita Srivastava, Joel D. Ernst Cell Host & Microbe Volume 15, Issue 6,
CATEGORY: PATHOGENS & DISEASE
Activation of T Lymphocytes
Cytokines: Introduction
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Cytokines Non-antibody proteins acting as mediators between cells, termed: Monokines – mononuclear phagocytes Lymphokines – activated T cells, especially.
Nutritional protective mechanisms against gut inflammation
Suzanne L. Topalian, Charles G. Drake, Drew M. Pardoll  Cancer Cell 
Immune Tolerance Kyeong Cheon Jung Department of Pathology
Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors
Figure 1 CTLA-4 and PD-1–PD-L1 immune checkpoints
Challenges in the Development of Effective Peptide Vaccines for Cancer
Autoimmune hepatitis – Update 2015
Tumor Immunology Ali Al Khader, MD Faculty of Medicine
Cancer Immunotherapy by Dendritic Cells
Oncology Meets Immunology: The Cancer-Immunity Cycle
Germaine Wong, Jeremy R. Chapman, Jonathan C. Craig 
The Th17 immune response in renal inflammation
Malaria Vaccine Design: Immunological Considerations
Colorectal cancer vaccines: Principles, results, and perspectives
T –HELPER CELL AMMAR HADI
Metastasis-Promoting Immunity: When T Cells Turn to the Dark Side
INTERLEUKIN 10 (IL-10) CATEGORY: RECEPTORS & MOLECULES
Ana C. Anderson, Nicole Joller, Vijay K. Kuchroo  Immunity 
Warren Strober, Ivan J. Fuss  Gastroenterology 
Leonardo V. Riella, Mohamed H. Sayegh  Kidney International Supplements 
Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC
Potential role for mucosally active vaccines against pneumococcal pneumonia  Kondwani C. Jambo, Enoch Sepako, Robert S. Heyderman, Stephen B. Gordon  Trends.
Interleukin-17 Kick-Starts T Helper 1 Cell Differentiation
Innate lymphoid cells in allergic and nonallergic inflammation
Mechanism of CTLA-4-induced immunosuppression.
Tilo Biedermann, Martin Röcken, José M. Carballido 
Etiology of Type 1 Diabetes
Immune Tolerance Kyeong Cheon Jung Department of Pathology
Yasmine Belkaid, Guillaume Oldenhove  Immunity 
Regulatory T Cells and Immune Tolerance
Designing Vaccines Based on Biology of Human Dendritic Cell Subsets
Volume 33, Issue 4, Pages (October 2010)
Mechanisms Underlying Inflammation in Neurodegeneration
A View to Natural Killer Cells in Hepatitis C
Tumor-Associated Macrophages: From Mechanisms to Therapy
Adiponectin: an enlarging role in acute kidney injury
Volume 143, Issue 1, Pages (July 2012)
Mycobacterial Infections and the Inflammatory Seesaw
Post kala-azar dermal leishmaniasis: an unresolved mystery
Nat. Rev. Urol. doi: /nrurol
Immunology Dr. Refif S. Al-Shawk
From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory Cells
Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe 
Recognizing Macrophage Activation and Host Defense
Linking Inflammasome Activation and Phagosome Maturation
Janine Bilsborough, Joanne L. Viney  Gastroenterology 
Figure 3 Underlying mechanisms of TREG cells in atherosclerosis
Tumor Immunology Ali Al Khader, MD Faculty of Medicine
Cell-mediated immunity Regulation of the immune response
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Sebastian Joyce, Luc Van Kaer  Cell Host & Microbe 
Regulatory T Cells in Asthma
Vaccines for Lung Cancer
Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell–mediated allergic inflammation  Yong-Jun Liu, MD, PhD  Journal.
Regulatory role of iNKT cells in T1D in humans and mice
Innate lymphoid cells in allergic and nonallergic inflammation
Antigen Smuggling in Tuberculosis
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Figure 1. Cross talk between the immune system and osteoclasts in osteoclastogenesis. Osteoclasts are derived from monocyte precursor cells. RANKL from.
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Post kala-azar dermal leishmaniasis: an unresolved mystery
Presentation transcript:

Tuberculosis in Africa: Learning from Pathogenesis for Biomarker Identification  Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe  Volume 4, Issue 3, Pages 219-228 (September 2008) DOI: 10.1016/j.chom.2008.08.002 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 From the Site of Action in the Lung to Biomarkers in the Peripheral Blood The figure depicts the major pathologic and protective mechanisms in the lung during latent Mtb infection and active TB disease. In addition, the picture indicates determination of immunologic, transcriptomic, and metabolomic biomarkers. Cell Host & Microbe 2008 4, 219-228DOI: (10.1016/j.chom.2008.08.002) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 Three Steps to T Cell Activation The figure shows three critical steps toward T cell activation and polarization. (1) T cells recognize antigen not in its natural form; rather the antigen is presented by reference structures encoded by the major histocompatibility complex (MHC). Antigens that reside in phagosomes are presented by MHC-II molecules to CD4 T cells. Because Mtb resides in phagosomes, this is the main antigen presentation/recognition pathway in TB. Antigens in the cytosol are loaded onto MHC-I molecules that present their antigens to CD8 T cells. Unconventional T cells comprising γδ T cells and CD1-restricted T cells are activated during Mtb infection, as well. Human γδ T cells recognize small molecules containing pyrophosphate residues, also termed phospholigands. The CD1-restricted T cells recognize mycobacterial glycolipids in the context of CD1 molecules. (2) CD4 T cells can be further subdivided into different T helper (Th) cells according to their cytokine expression pattern. The Th1 cells are critical for protection against TB. They typically produce interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), lymphotoxin (LT), interleukin (IL)-2, and granulocyte-macrophage colony-stimulating factor (GM-CSF). The Th2 cells stimulate humoral immune responses via secretion of IL-4 and IL-5. The Th17 cells produce IL-6, IL-17, IL-21, and IL-22, which probably contribute to early protection. The regulatory T cells (Treg) produce tumor growth factor beta (TGF-β) and IL-10, which suppress immune responses. Cytokines are also important for polarization of CD4 Th cells. Thus, IL-12, IL-18, and IFN-γ promote Th1 cell development; IL-33 together with IL-4 and IL-25 induce Th2 cell development; TGF-β, together with IL-6, promotes Th17 cell polarization in mice and TGF-β and IL-21 do so in humans, and TGF-β together with vitamin A derivates (retinoic acid, RA) favors Treg cell maturation. (3) For complete activation, T cells need to be costimulated by surface molecules. Many of these molecules belong to the B7 family. Thus, interactions of CD28 on T cells with B7.1 and/or B7.2 on antigen-presenting cells (APCs) promote T cell stimulation as do interactions of the inducible T cell costimulator (ICOS) on activated T cells with ICOSL (B7.h) on APCs. Other mechanisms are inhibitory such as interactions of B7.1 and B7.2 with CTLA-4 and interactions with PD-1 on activated T cells with PD-L on APCs. Cell Host & Microbe 2008 4, 219-228DOI: (10.1016/j.chom.2008.08.002) Copyright © 2008 Elsevier Inc. Terms and Conditions